AI-generated summary
The authors studied 31 people with major depressive disorder who received single transcranial near-infrared light sessions at different doses or sham while in an MRI scanner. They report that a medium continuous dose increased brain BOLD power, a low dose decreased it, and the high pulsed dose and sham showed no significant change. Single sessions did not significantly change depression severity compared with sham.
- Participants
- 31
- Who or what was studied
- Adults with major depressive disorder
- Wavelengths
- 808 nm
- Limits stated in the abstract
- The abstract describes a single acute session per dose in a modest sample, so findings on depression severity and longer-term effects are not established.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm
- Power density (irradiance)
- 300 mW/cm2, 50 mW/cm2
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Dose, Transcranial photobiomodulation, Sham, Functional magnetic resonance imaging, Near-infrared, Mitochondria, Depression. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.